Hematologist
CION Cancer Clinics
When childhood leukaemia comes back: treatment after relapse | CION Cancer Clinics
Relapsed childhood leukaemia is treated again, and the first aim is usually a second remission, meaning no leukaemia can be seen on tests. The plan depends on when it came back, where in the body, and how it responds to re-induction. Options include new chemotherapy, immune-based medicines, stem cell transplant and CAR-T. This page explains each step, and what it cannot tell you about your own child. At CION Cancer Clinics, our haematology team supports patients and families through treatment, cost questions and life at home.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Can relapsed childhood leukaemia still be treated?
- Where in the body can leukaemia come back?
- Does it matter when the leukaemia came back?
- What does treatment for relapsed leukaemia usually involve?
- What do the words on the report mean?
- What do parents often believe about relapse that is not true?
- What should you ask, and what can CION do?
- Common questions about relapsed childhood leukaemia
The short answer
Can relapsed childhood leukaemia still be treated?
Yes. When childhood leukaemia comes back, it is treated again, and the first aim is usually a second remission, meaning no leukaemia can be seen in the blood or bone marrow. The plan depends on when the leukaemia returned, where in the body it returned, and how it responds to the first weeks of new treatment.
What relapse means
Relapse means leukaemia cells have been found again after a period when tests showed none. It can happen during treatment, during the long maintenance phase at home, or after treatment has finished. It is not caused by something you did or missed at home, such as a late tablet or a cold.
Why the second plan is different
Leukaemia that returns has survived the first round of medicines, so the team usually changes the approach. That can mean stronger chemotherapy, newer immune-based medicines, a stem cell transplant, or CAR-T cell therapy. Most of this applies to acute lymphoblastic leukaemia (ALL), the most common type in children. Relapsed acute myeloid leukaemia (AML) follows a different path, which your team will explain.
This page cannot give you your child's outlook. No general figure can. Ask the treating haematologist what the tests mean for your child.Site of relapse
Where in the body can leukaemia come back?
Where the leukaemia returns shapes the treatment. Your child's report will usually name the site.
Bone marrow
The most common site. It is often found through a change in the blood count, tiredness, bruising or fever, and confirmed with a bone marrow test. It needs full treatment of the whole body.
Brain and spinal fluid
Leukaemia cells can hide in the fluid around the brain and spinal cord, where many medicines reach poorly. It may cause headaches, vomiting or changes in vision, or be found on a routine lumbar puncture.
Often treated with
- Chemotherapy into the spinal fluid
- Whole-body chemotherapy as well
- Sometimes radiotherapy
Testes
In boys, a swelling of one testis that does not hurt can be a sign. A biopsy (a small tissue sample) confirms it. Treatment covers the whole body, not only the swelling.
More than one site
Sometimes the marrow and another site are involved together. This is called a combined relapse, and the plan is built to reach both.
Not sure whether this applies to you?
Ask an oncologistTiming matters
Does it matter when the leukaemia came back?
Earlier relapse
Later relapse
Comes back during treatment or soon after it ends
Comes back well after treatment has finished
Suggests the leukaemia resisted the first medicines
Suggests the leukaemia may still respond to similar medicines
A stem cell transplant or CAR-T is more often discussed
Chemotherapy alone is more often enough, depending on response
Usually placed in a higher risk group
Often placed in a standard risk group, if the marrow test clears
The pathway
What does treatment for relapsed leukaemia usually involve?
-
Confirming the relapse
Blood tests, a bone marrow test and usually a lumbar puncture show where the leukaemia is and what kind of cells it has now. The cells can change between the first illness and the relapse, so they are tested again.
-
Re-induction
A first block of intensive treatment aims to clear the leukaemia again. Your child is often in hospital for parts of it, because infections are more likely while blood counts are low.
-
Checking the response
A marrow test looks for minimal residual disease (MRD), meaning tiny amounts of leukaemia left behind that a microscope cannot see. This result steers most of what comes next.
-
Deciding the next step
Depending on timing, site and MRD, the team may continue chemotherapy, add an immune-based medicine such as blinatumomab or inotuzumab, or plan a stem cell transplant or CAR-T at a qualified centre.
-
Recovery and follow-up
Whatever the route, follow-up continues for years, with blood tests and checks for late effects of treatment.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
On your child's report
What do the words on the report mean?
- Isolated relapse
- Leukaemia has come back in one place outside the bone marrow, such as the spinal fluid or testes, with the marrow still clear.
- Refractory
- The leukaemia did not clear with treatment. It is different from relapse, where it cleared and then returned.
- MRD positive or negative
- Whether tiny traces of leukaemia were found in a sensitive marrow test. Negative is the result the team hopes for.
- Second remission
- Remission means no leukaemia can be seen on tests. A second remission is reaching that point again after a relapse.
- CD19 or CD22
- Markers on the surface of the leukaemia cells. Some newer medicines and CAR-T target these markers, so they are checked again at relapse.
Commonly believed
What do parents often believe about relapse that is not true?
"It came back because we missed a tablet or let him play outside."
Relapse happens because some leukaemia cells survived treatment. It is not caused by a missed dose now and then, a festival outing or a cold. Carrying that blame drains the energy you need for the weeks ahead.
"A relapse means nothing more can be done."
Relapsed leukaemia in children is treated with a clear plan, and many options exist that did not a few years ago. The outlook depends on timing, site and response, and only your child's team can speak to that.
"Transplant is always the next step."
Not always. Some children with a later relapse do well with chemotherapy alone. A transplant carries its own serious risks, so it is offered where the benefit is judged to outweigh them.
"We should go abroad for anything to work."
Many of the treatments used for relapse, including transplant and CAR-T, are available at qualified centres in India. Ask the team where your child's treatment can be given closest to home.
Being straight with you
What should you ask, and what can CION do?
Start by asking three things: where the leukaemia has come back, how long after treatment it returned, and what the plan is for the next few weeks. Those answers explain most of the choices that follow.
Questions worth bringing to the appointment
Ask whether the leukaemia cells have been retested, and for which markers. Ask whether a transplant or CAR-T is being considered, and if so, when brothers and sisters should be tested as possible donors. Ask whether a clinical trial suits your child. Ask what you should watch for at home, and who to call at night.
What CION's haematology team does
CION's haematologists review your child's reports, present the case at a tumour board where several specialists decide together, and give chemotherapy and supportive care. CION does not perform stem cell transplants or CAR-T itself. Where those are needed, the team coordinates referral and access with qualified centres and stays involved.
Who this approach may not suit
Very intensive treatment is not right for every child. If the leukaemia is not responding or your child is too unwell, the focus can shift to comfort. Palliative care, meaning care that eases symptoms, can also run alongside active treatment from the start.
Questions we are asked
Common questions about relapsed childhood leukaemia
How do doctors know the leukaemia has come back?
Often a routine blood count shows a change, or your child has tiredness, bruising, fever or bone pain. Sometimes it is found on a planned marrow test or lumbar puncture. A relapse is confirmed with a bone marrow test and tests on the spinal fluid, not by a single blood count alone.
Is relapsed leukaemia treated with the same medicines as before?
Partly. Some of the same medicines may be used in a different combination or at a different intensity. The team often adds medicines your child has not had before, and may use immune-based treatment. The exact plan depends on when and where the leukaemia came back, and your child's earlier treatment.
Will my child need a stem cell transplant?
Not necessarily. A transplant is more often advised when relapse happens early, involves the marrow, or leaves traces on the MRD test after re-induction. Children with a later relapse and a good response may continue with chemotherapy. Transplants are done at specialist transplant centres, and the team will explain why one is or is not advised.
What is CAR-T, and is it available in India?
CAR-T uses your child's own immune cells, changed in a laboratory to recognise leukaemia, then given back through a drip. It is mainly used for B-cell ALL that has relapsed or not responded. CAR-T is available at a small number of qualified centres in India. Ask your haematologist whether your child could be eligible.
Can we continue treatment at the same hospital?
Often parts of it, yes. Re-induction chemotherapy and supportive care can usually continue with your current team. If a transplant or CAR-T is needed, that part happens at a centre that offers it, and your team should help with the referral and share all reports so nothing is repeated without reason.
Should we get a second opinion?
It is reasonable to ask for one at relapse, as the choices are bigger. Bring every report, including the first diagnosis, the treatment given and the latest marrow and MRD results. A good second opinion should not delay urgent treatment, so ask your current team whether starting re-induction should wait.
How do we manage the cost of treatment after relapse?
Costs can rise, especially if a transplant or CAR-T is needed. Ask about Aarogyasri, PM-JAY, CGHS, ECHS, EHS and your cashless insurance early, because approvals take time. Scheme rules change, so check the current rules for your child's treatment. Hospital social workers and charities may also help.
How do we explain a relapse to our child?
Be honest in words that suit their age. Children who have been through treatment before often sense that something has changed. Tell them the leukaemia has come back, that the doctors have a new plan, and that they are not to blame. Ask the team about a counsellor or child psychologist for support.
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — Childhood Acute Lymphoblastic Leukemia Treatment (PDQ)
- Cancer Research UK — Children's cancers: acute lymphoblastic leukaemia
- American Cancer Society — Treatment of children with acute lymphocytic leukemia
- Leukemia & Lymphoma Society — Childhood blood cancer
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Childhood leukaemia (ALL) guideThe full picture of childhood ALL from diagnosisCAR-T for Childhood LeukaemiaHow CAR-T works and who may be eligibleMRD in Childhood LeukaemiaThe marrow test that steers treatment after relapseRisk Groups in Childhood ALLHow the team decides treatment intensitySiblings During a Child's Leukaemia TreatmentSupporting brothers and sisters, including donor testing
Talk to us
Has your child's leukaemia come back?
Share the latest reports with us. Our haematology team will review them, explain the options and help coordinate referral where needed. One helpline serves every CION centre.